| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |